MaxCyte Inc (NASDAQ: MXCT) kicked off on Monday, up 3.96% from the previous trading day, before settling in for the closing price of $2.02. Over the past 52 weeks, MXCT has traded in a range of $2.00-$5.20.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -11.37%. While this was happening, its average annual earnings per share was recorded 5.81%. With a float of $97.66 million, this company’s outstanding shares have now reached $106.31 million.
The extent of productivity of a business whose workforce counts for 114 workers is very important to gauge. In terms of profitability, gross margin is 78.16%, operating margin of -133.05%, and the pretax margin is -110.92%.
MaxCyte Inc (MXCT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of MaxCyte Inc is 8.14%, while institutional ownership is 72.93%. The most recent insider transaction that took place on Jun 25 ’25, was worth 22,378. Before that another transaction happened on Mar 18 ’25, when Company’s Chief Commercial Officer sold 1,211 for $3.18, making the entire transaction worth $3,850. This insider now owns 59,439 shares in total.
MaxCyte Inc (MXCT) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 5.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.79% during the next five years compared to -11.37% drop over the previous five years of trading.
MaxCyte Inc (NASDAQ: MXCT) Trading Performance Indicators
Take a look at MaxCyte Inc’s (MXCT) current performance indicators. Last quarter, stock had a quick ratio of 11.58. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.40, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.35 in one year’s time.
Technical Analysis of MaxCyte Inc (MXCT)
The latest stats from [MaxCyte Inc, MXCT] show that its last 5-days average volume of 0.47 million was inferior to 0.76 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 27.80%.
During the past 100 days, MaxCyte Inc’s (MXCT) raw stochastic average was set at 5.92%, which indicates a significant decrease from 28.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.11 in the past 14 days, which was lower than the 0.16 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.23, while its 200-day Moving Average is $3.30.